hotspot -WSS

hotspot

author：entertainment 2025-09-28 00:48:46 - browse：223

A clipboard with checklist on blue dark background. -- health tech coverage from STAT — Adobe

A Pittsburgh artificial intelligence startup emerging as a challenger to Microsoft’s clinical note taking business has raised $150 million, a rare mega deal in a funding lull. The startup, Abridge, also has an unlikely cheerleader: Paul Ricci, the former head of Nuance, the service from Microsoft it competes with.

Abridge sells an AI tool that rapidly transcribes and summarizes doctors’ conversations with patients in a hospital’s electronic health records software. The startup’s leaders and investors tell STAT they’re betting that their medical knowledge, agility, and willingness to co-develop features with customers makes it a more attractive long term option than Nuance, which Microsoft says is currently used by most U.S. hospitals.

Microsoft, Abridge and other startups like Suki, Corti and Nabla are locked in a race to ease provider burnout by automating clinical note taking, and — thanks to generative AI — organizing the data in a way that could improve care, such as suggesting topics for follow-up, simplifying billing or analyzing trends at the broader patient population level.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： PBMs are inflating the cost of generic drugs. They must be reined in

explore

WSS

Meadows told special counsel he could not recall Trump ever declassifying Mar

People can get long Covid without testing positive for virus: Study

CDC says it’s too soon to assess risk posed by Covid subvariant

STAT Summit: Michael J. Fox on progress in Parkinson's research

Researchers explore possible ties between long Covid, menopause

Hospital price transparency does save money, advocate argues

explore

hotspot

leisure time

23andMe had bad news about my health. I wish a person had delivered it

STAT Summit: Michael J. Fox on progress in Parkinson's research

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Will Ozempic

The cancer drug shortage isn’t new — and neither are the solutions

STAT Readout Newsletter: Today's biggest biotech updates

FDA approval of Sarepta Duchenne genetic therapy gives me hope

STAT Readout Newsletter: Today's biggest biotech updates

How one medical school became remarkably diverse

Pharmacists can make shortage drugs, but at what cost?

hotspot

Can U.S. cancer drug shortages be fixed?

CDC says it’s too soon to assess risk posed by Covid subvariant

Why health workers in Gaza are injured or die at high rates

Intellia plays down concerns on accidental germline transmission

How to make over

How to make over

entertainment

leisure time

explore

explore